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Introduction: The proportion of elderly Americans admitted to the intensive care unit (ICU) in the last month of
life is rising. Hence, challenging decisions regarding the appropriate use of life support are increasingly common.
The objective of this study was to estimate the association between patient age and the rate of new limitations in
the use of life support, independent of daily organ dysfunction status, following acute lung injury (ALI) onset.
Methods: This was a prospective cohort study of 490 consecutive patients without any limitations in life support at
the onset of ALI. Patients were recruited from 11 ICUs at three teaching hospitals in Baltimore, Maryland, USA, and
monitored for the incidence of six pre-defined limitations in life support, with adjustment for baseline comorbidity
and functional status, duration of hospitalization before ALI onset, ICU severity of illness, and daily ICU organ
dysfunction score.
Results: The median patient age was 52 (range: 18 to 96), with 192 (39%) having a new limitation in life support in
the ICU. Of patients with a new limitation, 113 (59%) had life support withdrawn and died, 53 (28%) died without
resuscitation, and 26 (14%) survived to ICU discharge. Each ten-year increase in patient age was independently
associated with a 24% increase in the rate of limitations in life support (Relative Hazard 1.24; 95% CI 1.11 to 1.40)
after adjusting for daily ICU organ dysfunction score and all other covariates.
Conclusions: Older critically ill patients are more likely to have new limitations in life support independent of their
baseline status, ICU-related severity of illness, and daily organ dysfunction status. Future studies are required to
determine whether this association is a result of differences in patient preferences by age, or differences in the
treatment options discussed with the families of older versus younger patients.Introduction
The proportion of older Americans utilizing intensive care
in the last month of life has steadily increased over the
past two decades [1,2]. Moreover, the proportion of the
US population over 65 years old is expected to double
between 2000 and 2030 [3], with increasing demand for
intensive care [2,4,5]. Despite calls for increased discus-
sion and documentation of end-of-life wishes, such issues* Correspondence: turnbull@jhmi.edu
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with acute conditions requiring ICU admission.
The Study to Understand Prognoses and Preferences for
Outcomes and Risks of Treatments (SUPPORT), which
completed enrollment two decades ago, examined the
relationship between patient age and decisions to limit the
use of life support for patients hospitalized with nine life-
threatening diagnoses including acute respiratory failure
[6]. SUPPORT investigators found that, after adjusting
for patients’ baseline function, preferences, and prognosis,
older age was associated with higher rates of withholding
mechanical ventilation, surgery, and dialysis [7]. However,
the SUPPORT study could not evaluate whether older pa-
tients had higher rates of withholding because they experi-
enced greater organ dysfunction than younger patients.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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withdrawing ventilator support using longitudinal data
and found no association with age after controlling for
physician predictions about both short-term and long-term
patient outcomes [8]. To further investigate this question,
we analyzed a prospective cohort of critically ill patients
with acute lung injury (ALI), which includes longitudinal
data on daily organ dysfunction status throughout their
ICU stay. We hypothesized that although organ dysfunc-
tion during hospitalization is likely to impact decisions to
limit life support, patient age is directly associated with the
rate of new limitations independent of organ dysfunction.
Materials and methods
Study cohort
Between October 2004 and October 2007, mechanically
ventilated patients who met the American–European
Consensus criteria for ALI [9] were consecutively enrolled
from 13 ICUs at four teaching hospitals in Baltimore, MD,
USA [10]. The parent study’s primary aim was to evaluate
the longer-term outcomes of ALI survivors with a particu-
lar focus on the effect of low tidal volume ventilation and
other critical care therapies [11]. All patients in participat-
ing ICUs were evaluated daily for the presence of ALI by
trained research personnel along with study investigators.
Only patients who were able to understand or speak
English were considered for consent.
Patients in neurologic specialty ICUs were excluded to
avoid enrolling patients with head trauma or primary
neurologic disease. Other key exclusion criteria were:
pre-existing illness with a life expectancy of <6 months
(based on the judgment of the patient’s medical team);
pre-existing cognitive impairment (based on documenta-
tion in the medical record); no fixed address; transfer to
a study site ICU with pre-existing ALI of >24 hours dur-
ation; >5 days of mechanical ventilation before ALI; and
a pre-existing limitation in life support at the time of study
eligibility (except for a sole order for no cardiopulmonary
resuscitation (CPR) in the event of a cardiac arrest). For this
analysis we excluded research participants who had a sole
no-CPR order at ALI onset (n = 24), so that all participants
had no limitations in life support at ALI onset. In addition,
participants recruited from two ICUs at the Veterans Af-
fairs hospital study site (n = 6) were excluded because med-
ical records were inaccessible for independent verification
of limitations of life support at the time of this analysis.
Consequently, a total of 490 patients from 11 ICUs
were available for this analysis of patients’ index ICU
admission for ALI. The institutional review boards of
Johns Hopkins University and all participating study
sites approved this research, with a waiver of consent
allowing observational data to be collected from the
medical records during patients’ hospitalization (see
Acknowledgements).Primary outcome
Patient medical records were evaluated by trained study
personnel using a standardized data collection form. A
limitation in life support was defined as a physician order
or a clinical note documenting any of the following: no
CPR; do not reintubate; no vasopressors; no hemodialysis;
do not escalate care; or other limitation (for example,
comfort care only). These limitations were considered in
this analysis when initiated either with or without a con-
comitant decision to withdraw life support.
Primary exposure
The primary exposure for this analysis was patient age at
the time of study enrollment. To investigate for a potential
nonlinear relationship between age and the rate of limita-
tions in life support, we evaluated both linear spline terms
and age functions using fractional polynomials in multi-
variable models, and found no evidence of nonlinearity.
Hence, age was modeled as a continuous variable, with
results of the analysis reported for each 10-year increase
within the age distribution of the cohort.
Covariates
The following baseline patient characteristics were hy-
pothesized to be potentially associated with the use of life
support: sex, race (white vs. nonwhite) [12,13], history of
cancer (all previous diagnoses of leukemia, lymphoma,
solid tumors with metastatic disease, as well as solid tu-
mors without metastatic disease in the last 5 years) [14],
Charlson Comorbidity Index [15], Functional Comorbidity
Index [16] as a measure of functional status before
hospitalization, days of hospitalization before ALI onset,
and Acute Physiology and Chronic Health Evaluation II
severity of illness score [17] at ICU admission. Two orga-
nizational factors, hospital study site (site 1, 2, or 3) and
ICU type (medical vs. surgical), were also considered.
Finally, we also included the severity of daily dysfunction,
as a continuous variable, in each of six organ systems
(respiratory, circulatory, renal, hematologic, hepatic, and
central nervous system) during the ICU stay using the
Sequential Organ Failure Assessment (SOFA) score, which
gives a higher score (range: 0 to 4) for greater dysfunction
[18]. SOFA scores were missing for nine of 8,673 (0.10%)
days of observation. These scores were imputed by mul-
tiple imputation and included in analysis.
Statistical analysis
All patients were evaluated in this analysis until one of
three mutually exclusive events occurred: cardiac arrest,
discharge from the ICU, or a limitation in the use of life
support (as previously defined). No patients were lost to
follow-up, with all experiencing one of these three events.
A cause-specific hazard approach was used to separately
estimate the impact of age on limitations in life support
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cumulative incidence of each event over 28 days in the
ICU setting [19-21].
To estimate the overall association between patient
age and the rate of limitations in life support, we fit an
initial flexible parametric survival model [22-24] using
restricted cubic splines of the Weibull distribution with
four degrees of freedom, adjusting for all baseline covari-
ates. In this initial model, each organ system component
of the SOFA score from the day of ALI onset was
included as a baseline covariate. Next, to estimate the
direct association between patient age and the rate of limi-
tations in life support, independent of organ dysfunction
during the ICU stay, we added each of the six components
of the daily SOFA score as a time-varying covariate to the
initial model. Relative hazards (RHs) and 95% confidence
intervals (CIs) are reported.
Finally, for illustrative purposes, we derived and plotted
the 28-day cumulative incidence function from the initial
model to estimate the probability of each event (cardiac
arrest, limitation in life support, and ICU discharge) for a
prototypical patient with identical baseline characteristics
(median values for all baseline continuous covariates and
mode values for all binary covariates), but with varying
ages [19,25]. Analyses were conducted using STATA 11.0
(StataCorp, College Station, TX, USA).
Results
Patients included in this analysis ranged in age from 18
to 96 years old, with a median age of 52 (interquartile
range 42 to 62), while patients excluded because of aTable 1 Patient demographics and outcomes, by first event fo
All patients (N = 490) Discharge (n =
Age 52 (42 to 62) 48 (40 to 5
Female 43.5 46.0
Nonwhite 40.8 39.2
Oncology comorbidity 18.4 15
Charlson Comorbidity Index 2 (1 to 4) 1 (0 to 3





Days in hospital before ALI onset 2 (1 to 6) 2 (1 to 5
Medical ICU 80.4 74.9
APACHE II score at ICU admission 26 (20 to 33) 23 (19 to 2
SOFA score at ALI onset 9 (7 to 12) 8 (5 to 10
Survival to ICU discharge 56.3 100.0
Data presented as median (interquartile range) or percentage. ALI, Acute lung injur
Organ Failure Assessment.pre-existing no-CPR order at the time of ALI onset had
a median age of 62 (interquartile range 49 to 79). Of all
nonwhite patients (41%), 95% were African-American
(Table 1). One-half of all patients had been hospitalized
for <3 days before ALI onset. During follow-up, 192
patients (39%) had a limitation in life support before
ICU discharge or cardiac arrest, occurring a median 7.5
days (interquartile range 3 to 16 days) after ALI onset.
Of these patients, 113 (59%) had life support withdrawn
and died, 53 (28%) died without resuscitation efforts and
26 (14%) survived to ICU discharge (Figure 1). Patients
aged 70 to 79 years old had the shortest median time
from ALI onset to a limitation in life support, and pa-
tients ≥80 years old were most likely to have a limitation
in life support before ICU discharge or cardiac arrest
(Table 2).
In the initial survival model containing only baseline
covariates, age was significantly associated with the rate
of limitations in life support (RH, 1.32; 95% CI, 1.18 to
1.48), as was the hepatic component of the SOFA score
(RH, 1.25; 95% CI, 1.08 to 1.44) (Table 3). For a prototyp-
ical patient, the cumulative probability of ICU discharge,
cardiac arrest, and a limitation in life support during 28
days after ALI onset is displayed in Figure 2, with the esti-
mated probability (95% CI) of a limitation in life support
of 17% (9 to 24%) for a 40 year old, 29% (18 to 40%) for a
60 year old, and 46% (29 to 63%) for an 80 year old.
Adding the SOFA score as a time-varying covariate to
the initial model with only baseline covariates modestly
attenuated the relationship between patient age and the
rate of limitations in life support (RH, 1.24; 95% CI, 1.11llowing acute lung injury onset
By first event
235) Cardiac arrest (n = 63) Limitation in life support (n = 192)




) 3 (1 to 5) 3 (1 to 4)




) 2 (1 to 10) 3 (1 to 7)
84.1 85.9
9) 33 (22 to 38) 29 (22 to 35)
) 12 (8 to 14) 11 (8 to 14)
23.8 13.5
y; APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, Sequential
Figure 1 Patient trajectories and outcomes following acute lung injury onset. Percentages in boxes represent the proportion of all 490
patients with the characteristic or outcome. Percentages along the arrows refer to the proportion of patients who transitioned to the outcome
described in the box where the arrow terminates. Proportions do not sum to 100% due to rounding. ALI, acute lung injury; CPR, cardiopulmonary
resuscitation.
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neurologic status significantly associated with the rate of
limitations (Table 3). Older age was not significantly asso-
ciated with the rate of ICU discharge (RH, 1.04; CI, 0.94
to 1.15) or cardiac arrest (RH, 0.86; CI, 0.70 to 1.05).
Discussion
In this multisite, prospective cohort study of 490 pa-
tients with acute lung injury, each 10-year increase in
patient age was associated with a 24% increase (95% CI
11 to 40%) in the rate of new limitations in life support,
after accounting for differences in baseline status, ICU
severity of illness, daily organ dysfunction, and the com-
peting risks of ICU discharge and cardiac arrest. Adding
longitudinal data on daily organ dysfunction status toTable 2 Selected patient characteristics and outcomes, by dec
<40 40 t
Number of patients (n) 94 1
Charlson Comorbidity Index 1 (0 to 4) 2 (1
Functional Comorbidity Index 1 (0 to 1) 1 (0
APACHE II score at ICU admissiona 24 (20 to 33) 24 (19
First eventb
Cardiac arrest 15 1
ICU discharge 60 5
Limitation in life support 26 3
Days from ALI onset to limitation in life supportc 8 (6 to 19) 7 (3
Data presented as median (interquartile range) or percentage, unless otherwise stat
Evaluation. aAPACHE II scores include points awarded for patient age. After removin
category are as follows: <40, 24 (20 to 33); 40 to 49, 23 (18 to 32); 50 to 59, 25 (18 t
bProportions may not sum to 100% due to rounding. cAmong patients with a limitathe initial model with baseline patient and ICU data atten-
uated the association between age and the rate of limita-
tions in life support, suggesting that organ dysfunction
may be a mediator in the age-limitation relationship but
does not fully explain the association.
Our findings expand upon the findings of prior studies
that have evaluated the relationship between age and the
limitation of life support [26], and suggest that factors
arising after hospital admission, rather than only a
patient’s status before hospitalization, are important
for understanding new limitations in the ICU setting.
A 2011 systematic review reported that age was one
of the most consistent patient characteristics influencing
decisions about end-of-life care [27]. However, most studies
in this systematic review used scenario-based surveys thatade of age
Patient age
o 49 50 to 59 60 to 69 70 to 79 ≥80
25 236 74 45 26
to 4) 2 (1 to 4) 3 (1 to 4) 3 (2 to 4) 3 (2 to 4)
to 2) 1 (0 to 3) 2 (1 to 3) 3 (2 to 4) 3 (1 to 4)
to 33) 28 (21 to 33) 27 (20 to 34) 28 (20 to 36) 29 (21 to 35)
3 13 8 13 15
8 41 43 38 23
0 45 49 49 62
to 19) 9 (3 to 16) 7 (3 to 13) 4 (2 to 10) 11 (4 to 16)
ed. ALI, acute lung injury; APACHE, Acute Physiology and Chronic Health
g these points, the median and interquartile range of scores for each age
o 31); 60 to 69, 22 (16 to 29); 70 to 79, 23 (15 to 30); ≥80, 23 (15 to 29).
tion in life support before ICU discharge or cardiac arrest.
Table 3 Cause-specific relative hazardsa for limitation of life support in 490 patients with acute lung injury
Baseline modelb Time-varying modelb
Patient demographic at enrollment RH (95% CI) P value RH (95% CI) P value
Age (10-year increase) 1.32 (1.18 to 1.48) 0.001 1.24 (1.11 to 1.40) 0.001
Female 0.99 (0.73 to 1.34) 0.96 0.97 (0.71 to 1.32) 0.86
Nonwhite 1.23 (0.89 to 1.70) 0.21 1.37 (0.99 to 1.92) 0.06
Cancer history 1.18 (0.78 to 1.79) 0.42 1.59 (1.04 to 2.43) 0.03
Charlson Comorbidity Index 1.02 (0.96 to 1.09) 0.53 0.98 (0.92 to 1.05) 0.58
Functional Comorbidity Index 1.00 (0.90 to 1.10) 0.94 1.03 (0.93 to 1.14) 0.53
Study site hospital
1 (reference group) Reference Reference Reference Reference
2 1.19 (0.81 to 1.77) 0.38 1.32 (0.90 to 1.94) 0.15
3 1.14 (0.75 to 1.73) 0.55 1.13 (0.76 to 1.69) 0.54
Days in hospital before ALI onset (1-day increase) 1.01 (0.99 to 1.02) 0.29 0.99 (0.98 to 1.00) 0.01
Medical ICU 1.92 (1.20 to 3.07) 0.007 1.87 (1.16 to 3.02) 0.01
APACHE II score at ICU admission 1.02 (0.99 to 1.04) 0.15 0.99 (0.97 to 1.01) 0.28
Components of SOFA score
Respiratory 0.93 (0.75 to 1.15) 0.50 1.19 (1.02 to 1.40) 0.03
Cardiovascular 1.06 (0.96 to 1.17) 0.28 1.47 (1.33 to 1.63) 0.001
Hepatic 1.25 (1.08 to 1.44) 0.002 1.17 (1.03 to 1.33) 0.01
Coagulation 1.10 (0.96 to 1.27) 0.18 1.23 (1.07 to 1.41) 0.004
Renal 1.05 (0.93 to 1.18) 0.43 1.15 (1.03 to 1.29) 0.02
Neurologic 1.01 (0.90 to 1.14) 0.82 1.10 (0.98 to 1.22) 0.10
ALI, acute lung injury; APACHE, Acute Physiology and Chronic Health Evaluation; CI, confidence interval; RH, relative hazard; SOFA, Sequential Organ Failure
Assessment. aThe relative hazard describes the relative risk of a new limitation in life support on a specific day in the ICU among patients who have not had a
cardiac arrest or been discharged from the ICU. For example, a patient with a relative hazard of 1.59 has a 59% increased risk of having a limitation in life support
that day compared with the reference patient if neither patient has a cardiac arrest or is discharged from the ICU. bThe baseline model was adjusted for each
component of SOFA score on the day of ALI onset. The time-varying model was adjusted for each component of SOFA score on all days in the ICU prior to the
day of first event. Both models are adjusted for sex, race, oncology comorbidity, Charlson Comorbidity Index, Functional Comorbidity Index, study site hospital,
days in hospital before ALI onset, ICU type, and APACHE II score at ICU admission.
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that did not include data on patients’ condition following
hospital admission. New limitations in life support, some-
times made after days or weeks in the ICU, were signifi-
cantly associated with organ dysfunction for five of the six
separate organ systems evaluated daily, but not with
baseline characteristics such as comorbidity or physical
functional status.
Our results highlight that a patient’s resuscitation
status at ICU admission should not be viewed as static.
None of the 490 patients evaluated in this study had any
limitation in life support while receiving mechanical venti-
lation at ALI onset in the ICU, but 39% had at least one
limitation before cardiac arrest or ICU discharge. Very
few patients with ALI are able to communicate or partici-
pate in clinical decision-making. New limitations occur-
ring after enrollment in this study are thus likely to reflect
decisions made by a surrogate decision-maker who is
typically a close family member. These surrogates and
physicians are faced with determining what treatments
and interventions patients wish to receive based on pastdiscussions and knowledge of the patient’s values and
preferences. Without data on such discussions, we cannot
infer whether the higher rate of limitations among older
patients in this study reflects patients’ wishes, or surro-
gates’ and physicians’ assumptions about the preferences
of older patients. This is consistent with Cook and col-
leagues’ 2003 study, which found that physician prediction
regarding a patient’s preference for the use of life support
was strongly associated with a decision to withdraw mech-
anical ventilation [8].
Are assumptions that older patients are less likely to
elect life-supporting interventions correct? Two decades
ago, older patients in the SUPPORT study were less
likely to elect CPR than similar younger patients [28],
but families and healthcare providers also underesti-
mated older patients’ desire for aggressive life-sustaining
treatments [29]. Smaller, more recent studies suggest
that older patients in the United States are more likely
to be asked about resuscitation status at hospital admis-
sion independent of illness severity [30], but are also less
likely to receive end-of-life care consistent with their
Figure 2 Estimated probability of cardiac arrest, limitation in life support, and ICU discharge, by patient age. Estimated probability of
cardiac arrest, limitation in life support, or ICU discharge for a typical patient in this acute lung injury (ALI) cohort (male patient hospitalized for 2
days before ALI onset, without any oncology comorbidity in a medical ICU at hospital site 1 with median values for Acute Physiology and
Chronic Health Evaluation II, Functional Comorbidity Index, Charlson Comorbidity Index, and Sequential Organ Failure Assessment scores) at the
time of enrollment. The cumulative incidence of each outcome was obtained through estimation using the initial model containing all baseline
covariates. The figure has been truncated at 28 days; hence, the cumulative probability of all events does not reach 100% because 11% of
patients had their first event more than 28 days after ALI onset. From left to right, the panels present the estimated probability of events when
the patient is age 40, 60, and 80.
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observed possibly reflects differences in long-held, gen-
erational attitudes about end-of-life care. However, a
recent study of more than 118,000 long-term nursing
home residents found that 40% of residents who wished
to receive CPR at enrollment changed their minds within
5 years, suggesting that patient preferences change over
time [32]. Finally, it is possible that life-sustaining inter-
ventions are more likely to be perceived as inappropriate
in older patients. Reports of disproportionately aggressive
treatment for patients who are unlikely to benefit are not
uncommon among clinicians in Europe, Israel, and the
United States [33,34].
There are potential limitations to this study. First, only
71 patients in the study cohort were more than 70 years
old. This both limits our power to estimate the effect of
age for older patients [35,36] and may explain why we
did not observe an exponential increase in the rate of
limitations among the oldest patients, as previously ob-
served in the SUPPORT cohort [7]. Nonetheless, the
cohort comprised consecutively admitted patients at 11
ICUs in three hospitals and the distribution of patient
ages was nearly identical to a large cohort of ALI patients
at US academic hospitals [37]. Second, our broad defin-
ition of a limitation in life support means our results are
not directly comparable with previous studies that focusexclusively on the relationship between age and cardio-
pulmonary resuscitation preference, ICU admission, or
decisions to withdraw mechanical ventilation. However,
we believe that the broader definition used in this study
better reflects the range of decisions made in an ICU set-
ting about the use of life-sustaining interventions. Third,
the study cohort excluded patients with cognitive dysfunc-
tion. The role of age in decisions about the use of life sup-
port may be quite different for these patients, and this is a
fertile area for future research as the number of people
with dementia climbs. Finally, our study was limited to
academic, tertiary-care hospitals in a single city. The high
in-hospital mortality observed in this study is consistent
with prior ALI studies conducted in university-affiliated
hospitals in North America [27,28,37,38], but geographic
variability in the use of medical interventions at the
end of life may make our results less generalizable to
other settings [39,40].
Conclusions
Older critically ill patients with ALI are more likely to
have new limitations in life support in the ICU independ-
ent of other predictors, including baseline demographics,
comorbidity, and functional status, and ICU severity
of illness and daily organ dysfunction status. Further
study is needed to determine whether the greater rate
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flection of barriers to end-of-life care discussions with
families of younger patients, or of family or physician
beliefs, which could be accurate or inaccurate, about
the preferences of older patients.
Key messages
 Patients’ resuscitation status during critical illness is
dynamic. In this cohort of 490 patients with no
limitations in life support at ALI onset, 39% had new
limitations in life support before cardiac arrest or
ICU discharge.
 Older patient age was associated with an increased
rate of limitations in life support after adjusting for
all baseline covariates and daily ICU organ
dysfunction status.
 Higher rates of limitations in life support among
older patients are not primarily a result of older
patients’ baseline comorbidity or functional status,
nor a result of greater organ dysfunction following
ALI onset.
 Future studies should investigate whether higher
rates of limitations among older patients are a result
of differences in patient preferences by age, or
differences in the treatment options discussed with
the families of older versus younger patients.
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